13F filer · CIK 1496201
SPHERA FUNDS MANAGEMENT LTD.
TEL AVIV, L3 · filing since Q4 2013 · last filing Aug 14, 2026
Reported value
$766.5M
+$136.9M vs prior
Positions
105
New / sold out
27 / 18
Added / reduced
33 / 30
Turnover
28.4%
buys $229.3M · sells $198.5M
Top-10 weight
34.5%
Biggest buys vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| New | BIOGEN INCCALL | +100,000 | – | +$21.6M |
| Added | CYTOKINETICS INC | +180,170 | +452.5% | +$15.3M |
| New | INSMED INC | +118,800 | – | +$12.7M |
| Added | TEVA PHARMACEUTICAL INDS LTD | +363,107 | +31.9% | +$12.3M |
| Added | BIOMARIN PHARMACEUTICAL INC | +188,650 | +134.8% | +$10.8M |
| New | RHYTHM PHARMACEUTICALS INC | +80,400 | – | +$8.9M |
| New | LAM RESEARCH CORP | +18,470 | – | +$8.0M |
| New | APPLIED MATLS INC | +11,040 | – | +$8.0M |
| New | IDEAYA BIOSCIENCES INC | +196,408 | – | +$7.3M |
| New | NUVECTIS PHARMA INC | +382,945 | – | +$7.0M |
50 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Biggest sells vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Reduced | CURIS INC | -1,895,941 | -95.0% | $-19.8M |
| Reduced | NOVA LTD | -28,197 | -52.8% | $-15.3M |
| Reduced | CYTOKINETICS INCCALL | -159,300 | -61.4% | $-13.6M |
| Reduced | TOWER SEMICONDUCTOR LTD | -37,470 | -25.7% | $-9.8M |
| Sold out | AMICUS THERAPEUTIC | -603,377 | -100.0% | $-8.7M |
| Sold out | CELLEBRITE DI LTD | -631,521 | -100.0% | $-8.7M |
| Sold out | APELLIS PHARMACEUTICALS INC | -214,914 | -100.0% | $-8.6M |
| Sold out | PALO ALTO NETWORKS INC | -52,800 | -100.0% | $-8.5M |
| Sold out | CAMTEK LTD | -53,020 | -100.0% | $-8.0M |
| Reduced | SPDR SERIES TRUSTPUT | -50,000 | -25.0% | $-7.9M |
38 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | TEVA PHARMACEUTICAL INDS LTDSPONSORED ADS | 1,500,082 | $50.8M | 6.63% |
| 2 | MINERALYS THERAPEUTICS INCCOM | 1,469,971 | $39.7M | 5.17% |
| 3 | TOWER SEMICONDUCTOR LTDSHS NEW | 108,265 | $28.2M | 3.68% |
| 4 | SPDR SERIES TRUSTPUTST STR SP BIOT | 150,000 | $23.7M | 3.10% |
| 5 | SYNDAX PHARMACEUTICALS INCCOM | 1,014,606 | $22.2M | 2.89% |
| 6 | BIOGEN INCCALLCOM | 100,000 | $21.6M | 2.82% |
| 7 | BIOGEN INCCOM | 96,626 | $20.9M | 2.72% |
| 8 | ULTRAGENYX PHARMACEUTICAL INCOM | 588,494 | $19.6M | 2.56% |
| 9 | BIOMARIN PHARMACEUTICAL INCCOM | 328,550 | $18.8M | 2.45% |
| 10 | CYTOKINETICS INCCOM NEW | 219,987 | $18.7M | 2.44% |
95 more rows. Subscribe for $29/month to see every row, download the data and use the API.